Latest news
NRDS: Q2 revenue up 6% year-over-year; major investments planned for vertical integration and IRR-based growth - TradingViewTradingView · Thu, 06 Aug 2026 22:12:15 GMTEraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 12:24:17 GMTPiramal Alternatives exits Biodeal Pharma investment with over 20% IRR - Indian Pharma PostIndian Pharma Post · Mon, 27 Jul 2026 09:41:14 GMT